ecteinascidin 743 has been researched along with plitidepsin in 11 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (plitidepsin) | Trials (plitidepsin) | Recent Studies (post-2010) (plitidepsin) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 129 | 23 | 51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| D'Incalci, M | 1 |
| Albella, B; Bueren, JA; Faircloth, G; Guzmán, C; Jimeno, J; López-Lázaro, L | 1 |
| Jimeno, JM | 1 |
| Taguchi, T | 1 |
| Albella, B; Bueren, JA; Faircloth, GT; Gómez, SG; Jimeno, J | 1 |
| Izquierdo, MA; Jimeno, J; López-Martín, JA; Rinehart, K; Ruiz-Casado, A; Scheuer, PJ | 1 |
| D'Incalci, M; Damia, G; Erba, E; Garbi, A; Simone, M; Tavecchio, M | 1 |
| O'Hanlon, LH | 1 |
| Allavena, P; D'Incalci, M; Galmarini, CM | 1 |
| Arizza, V; Lazzara, V; Mauro, M; Punginelli, D; Vazzana, M | 1 |
| Chittepu, VCSR; Gallardo-Velazquez, T; Kalhotra, P; Osorio-Revilla, G | 1 |
6 review(s) available for ecteinascidin 743 and plitidepsin
| Article | Year |
|---|---|
A clinical armamentarium of marine-derived anti-cancer compounds.
Topics: Animals; Antineoplastic Agents; Depsipeptides; Dioxoles; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Marine Biology; Mollusca; Peptides; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin | 2002 |
[Development of marine-derived anti-cancer compounds].
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Depsipeptides; Dioxoles; Female; Humans; Isoquinolines; Male; Marine Biology; Mollusca; Neoplasms; Peptides; Peptides, Cyclic; Porifera; Survival Analysis; Tetrahydroisoquinolines; Trabectedin; Urochordata | 2003 |
Progress in the clinical development of new marine-derived anticancer compounds.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chemistry, Pharmaceutical; Clinical Trials as Topic; Depsipeptides; Dioxoles; Humans; Isoquinolines; Marine Biology; Neoplasms; Peptides; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin | 2004 |
New drugs from the sea.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Depsipeptides; Dioxoles; Humans; Isoquinolines; Marine Biology; Peptides, Cyclic; Pharmaceutical Preparations; Sensitivity and Specificity; Structure-Activity Relationship; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2004 |
Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment.
Topics: Animals; Antineoplastic Agents; Aquatic Organisms; Cell Death; Cell Survival; Depsipeptides; Dioxoles; Disease Progression; Humans; Molecular Targeted Therapy; Neoplasms; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin; Tumor Microenvironment | 2014 |
Antitumoral compounds from vertebrate sister group: A review of Mediterranean ascidians.
Topics: Animals; Antineoplastic Agents; Biological Products; Depsipeptides; Humans; Mediterranean Sea; Neoplasms; Peptides, Cyclic; Trabectedin; Urochordata | 2020 |
5 other study(ies) available for ecteinascidin 743 and plitidepsin
| Article | Year |
|---|---|
Editorial comment on "In vitro toxicity of ET-743 and Aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors: comparison with the clinical results" by Albella and colleagues.
Topics: Antineoplastic Agents, Alkylating; Bone Marrow Diseases; Depsipeptides; Dioxoles; Hematopoietic Stem Cells; Humans; Isoquinolines; Megakaryocytes; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin | 2002 |
In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors. comparison with the clinical results.
Topics: Antineoplastic Agents; Bone Marrow Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Depsipeptides; Dioxoles; Doxorubicin; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Isoquinolines; Neoplasms; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2002 |
In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells.
Topics: Animals; Antineoplastic Agents; Cell Survival; Depsipeptides; Dioxoles; Hematopoietic Stem Cells; Isoquinolines; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Peptides; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin | 2003 |
Scientists are searching the seas for cancer drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Depsipeptides; Dioxoles; Ethers, Cyclic; Furans; Humans; Isoquinolines; Ketones; Macrolides; National Institutes of Health (U.S.); Oceans and Seas; Peptides, Cyclic; Seawater; Tetrahydroisoquinolines; Trabectedin; United States | 2006 |
Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors.
Topics: Catalytic Domain; Depsipeptides; Drug Repositioning; Furans; Humans; Ketones; Models, Molecular; Molecular Docking Simulation; Peptide Hydrolases; Peptides, Cyclic; Quantitative Structure-Activity Relationship; SARS-CoV-2; Serine Proteinase Inhibitors; Trabectedin; Viral Proteins; Virus Replication | 2021 |